| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000246792.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04525645 |
Resistant |
| ENSG00000246792.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.038671776 |
Resistant |
| ENSG00000246792.2 |
Cytarabine |
Skin cutaneous melanoma |
0.047564691 |
Sensitive |
